Osteopontin level and promoter polymorphism is associated with aggressiveness in breast cancer von Elbaiomy, M.A., El-Ghonemy, M.S., Elhelaly, R., Elzehery, R.

Volltext

Osteopontin level and promoter polymorphism in patients with metastatic breast cancer von Elbaiomy, M A, Akl, T, Elhelaly, R, El-Beshbishi, W, El Ghonemy, M S, Elzehery, R

Volltext

Thyroid gland dysfunction and vitamin D receptor gene polymorphism in keratoconus von Awad, Eman A., Torky, Magda A., Bassiouny, Rania M., Khattab, Abeer M., Elzehery, Rasha R., Elhelaly, Rania M.

Volltext

Could Rifaximin Modify the Pathogenesis of Nafld? Multicentric Study von Abdel-Razik, A, Mousa, N, Elbaz, S, Shabana, W, El-Wakeel, N, Effat, N, Refaey, M, Elzehery, R, Elkashef, W, Hafez, M, Awad, M, Zalata, K, Eldars, W

Volltext

Circulating Cell Free DNA and DNA Integrity Index as Discriminating Tools between Breast Cancer and Benign Breast Disease von Elhelaly, Rania, Effat, Narmen, Abd El-Fattah Hegazy, Mohamed, Abdelwahab, Khaled, Hamdy, Omar, Abo Hashem, Ekbal M, Elzehery, Rasha R

Volltext

Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot von Abdel-Razik, Ahmed, Mousa, Nasser, Shabana, Walaa, Refaey, Mohamed, Elzehery, Rasha, Elhelaly, Rania, Zalata, Khaled, Abdelsalam, Mostafa, Eldeeb, Ahmed A, Awad, Mahmoud, Elgamal, Ayman, Attia, Ahmed, El-Wakeel, Niveen, Eldars, Waleed

Volltext

378 (PB-011) - Osteopontin level and promoter polymorphism is associated with aggressiveness in breast cancer von Ali, M., Sabry El-Ghonemy, M., Elhelaly, R., Elzehery, R.

Volltext

Osteopontin level and promoter polymorphism is associated with aggressiveness in breast cancer von Ali, M., Sabry El-Ghonemy, M., Elhelaly, R., Elzehery, R.

Volltext

43POsteopontin level and promoter polymorphism is associated with aggressiveness in breast cancer von Elbaiomy, M A, El-Ghonemy, M S, Elhelaly, R, Elzehery, R

Volltext

Osteopontin Level and Promoter Polymorphism in Patients with Metastatic Breast Cancer von Elbaiomy, M A, Akl, T, Elhelaly, R, El-Beshbishi, W, El Ghonemy, M S, Elzehery, R

Volltext

FRI-272 - Could Rifaximin Modify the Pathogenesis of Nafld? Multicentric Study von Abdel-Razik, A., Mousa, N., Elbaz, S., Shabana, W., El-Wakeel, N., Effat, N., Refaey, M., Elzehery, R., Elkashef, W., Hafez, M., Awad, M., Zalata, K., Eldars, W.

Volltext

Helicobacter pylori and non‐alcoholic fatty liver disease: A new enigma? von Abdel‐Razik, Ahmed, Mousa, Nasser, Shabana, Walaa, Refaey, Mohamed, Elhelaly, Rania, Elzehery, Rasha, Abdelsalam, Mostafa, Elgamal, Ayman, Nassar, Mervat R., Abu El‐Soud, Atef, Seif, Ahmed S., Tawfik, Ahmed M., El‐Wakeel, Niveen, Eldars, Waleed

Volltext